Sep 06, 2023 / 04:45PM GMT
Unidentified Participant -
Well, Magnus, thank you for coming here today and come back again for the Barclays Consumer Staples Conference. And thank you for those attendance here. Also, I know we'll have the webcast people online. So thank you for your interest in Essity and Barclays. So there's a lot to touch on. Very busy in Essity in the last 12 months -- and I think a good place start maybe the strategic review, just on where we are in the process with Vinda and maybe the private label business?
Questions and Answers:
Magnus Groth - Essity AB(publ)-President - CEO & DirectorAbsolutely. Yes. We are -- as you know, looking at Vinda, the private (inaudible) business in Consumer Tissue in Europe, and the strategic reviews could include loss of divesting these businesses. And when it comes to Vinda, I think it's quite well known now that we have a process running, and that process is running well, but it will be another couple of quarters before we see how that plays out.
Private label is maybe in an earlier
Trustpilot
